What's Trending in the Molecular World

Novel cancer treatment wins endorsement of FDA advisers


Food and Drug Administration advisers on Wednesday enthusiastically endorsed a first-of-its-kind cancer treatment that uses patients’ revved-up immune cells to fight the disease, concluding that the therapy’s benefits for desperately ill children far outweigh its potentially dangerous side effects.

Read more here.

Patient-centered drug manufacture


Bedside production of protein drugs could help payers by lowering drug prices. It may ultimately lead to individualized treatments. Read more here.